NeuraLight announces $25M in Series A funding

Digitizing
Neurology

Transforming clinical development, diagnostics, and precision medicine in neurology with AI.

Digitizing
Neurology
Scroll
Challenge

Presently, neurological evaluation is highly subjective, non-sensitive, and dependent on manual examination of symptoms, posing a significant challenge for timely diagnosis, patient monitoring, drug development, and precision care.

  • Leadership
  • Board of Directors
  • Advisory Board
Micha Breakstone, PhD
Micha Breakstone, PhD
CEO & Co-founder
Edmund Benami
Edmund Benami
CTO & Co-founder
Gil Shklarski, PhD
Gil Shklarski, PhD
Scientific Co-founder
Rivka Kreitman, PhD
Rivka Kreitman, PhD
Chief Innovation Officer
Vova Anisimov
Vova Anisimov
Head of Engineering
Tzvika Cohen
Tzvika Cohen
Head of Operations
Eli Groner
Eli Groner
Director
Jonathan Soberg
Jonathan Soberg
Director
Tamara Minick-Scokalo
Tamara Minick-Scokalo
Observer
Jon Galitzer
Jon Galitzer
Observer
Prof. Alvin Roth, PhD
Prof. Alvin Roth, PhD
Prof. Olivier Rascol, MD, PhD
Prof. Olivier Rascol, MD, PhD
Prof. Fred Lublin, MD
Prof. Fred Lublin, MD
Prof. Ruth Djaldetti, MD
Prof. Ruth Djaldetti, MD
Afik Gal, MD, MBA
Afik Gal, MD, MBA
Marta Bralic Kerns
Marta Bralic Kerns
Prof. Thomas C. Südhof, MD, PhD
Prof. Thomas C. Südhof, MD, PhD
Active Research

We are currently conducting research on novel biomarkers for several neurological disorders.

Newsroom
  • Any
  • Press Coverage
  • Press Releases

Partnerships

We are looking to partner with pharmaceutical and biotech companies, academic research institutions, clinical centers, patient advocacy groups, and other organizations promoting solutions for treatment of neurodegenerative diseases.

Name
Job
Bio